ArticleNeurochemical research2026
ApoTransferrin Induces Accumulation of Lipid Droplets in Oligodendroglial Cell.
Article in Neurochemical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Transferrin is the principal iron-carrier protein and is primarily synthesized in the liver, oligodendrocytes (OLG), and choroid plexus. We previously demonstrated that apotransferrin (aTf) treatment induces OLG maturation in vitro and in vivo. Given that approximately 80% of myelin consists of lipids, predominantly cholesterol, tight regulation of lipid metabolism is essential during myelin formation. Lipid droplets (LDs) are dynamic intracellular organelles that store fatty acids as neutral lipids, including triglycerides and cholesterol esters. Recent studies have demonstrated the presence and regulated turnover of LDs in glial cells, suggesting roles in both physiological and pathological processes. During OLG maturation, the demand for lipid synthesis increases markedly to sustain membrane expansion and myelin production. Because this high lipid demand, we hypothesized that aTf-induced OLG maturation is associated with metabolic reprogramming involving lipid droplet dynamics, which may serve as a source of fatty acids for membrane biogenesis and energy production. In this context, LDs may represent a critical metabolic hub through which OLGs regulate lipid homeostasis and adapt to increased bioenergetic demands. However, the mechanisms governing LD biogenesis and turnover in oligodendroglial cells during development and under different metabolic conditions remain poorly understood. Importantly, LDs are now recognized as active participants in cellular metabolism, stress responses, and membrane biogenesis rather than passive lipid storage compartments. The aim of this study is to characterize LD dynamics, as well as specific lipid and protein profiles, in the Oli-Neu cell line and in oligodendroglial cells during the maturation process in the presence of aTf. We specifically investigate whether the aTf-induced increase in LD abundance reflects enhanced membrane biosynthetic requirements, with augmented energy production supported by β-oxidation of fatty acids released from triglycerides stored within LDs.
Indexed as
Identifiers
42501177What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.